However, in experimental VL in mice [47] and in human visceral leishmaniasis [37], IL-10 comes from non-T reg cells (CD4+CD25−FoxP3−), indicating that therapeutic approaches require Leishmania species-specific understanding of the immune response. The gene discussed is IL10; the disease is visceral leishmaniasis.